Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which ...
Heart rhythm monitoring in the weeks before cardioversion therapy for atrial fibrillation/atrial flutter reduced the ...
Read more about the potential of smartphone-based heart rhythm technology in reducing unnecessary hospital visits.
Sweden: Researchers have found in a new study that pre-cardioversion rhythm monitoring using smartphone-based ...
Please provide your email address to receive an email when new articles are posted on . “Cryoconvergent” hybrid ablation for atrial fibrillation may significantly reduce risk for recurrent AF and AF ...
A tailored approach to atrial fibrillation ablation, applying a variety of complementary ablation strategies in a stepwise fashion with defined endpoints, could alter the way in which ablation is ...
It is unclear which factors are associated with progressive sinus node dysfunction after cavotricuspid isthmus (CTI)-dependent atrial flutter (AFL) ablation. We sought to evaluate the incidence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results